Long Rhode Island Cardiology Center None None None None None None None Christopher M. O Connor Duke Clinical Research Institute, Duke University Medical Center None None None None None None None Patrick T. O Gara Brigham & Women s Hospital None None None None None None None Gbenga Ogedegbe NYU School of Medicine NIH None None None None None None (Continued) Suzanne Oparil University of Alabama at Birmingham Medtronic*; Merck & Co ; Novartis ; Takeda None None None None Bayer*; Daiichi Sankyo*; Pfizer* None William B. White University of Connecticut School of Medicine NIH (study of ambulatory blood pressure monitoring guided therapy to reduce functional decline in older persons) ; NIH (Impact of smoking cessation on blood pressure, SNS activity) None None None None None None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be significant if (a) the person receives $10000 or more during any 12-month period, or 5% or more of the person s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition. *Modest. Significant. 